Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Rodney S. Markin currently holds 263,430 shares of Cardiff Oncology, Inc. (CRDF), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rodney S. Markin has been a net buyer of CRDF stock. They have purchased $130.0K and sold $0 worth of shares.
Rodney S. Markin's most recent insider trade was on Jun 11, 2026, when they sold 40,565 shares at $0.00 per share.
Rodney S. Markin serves as Executive at Cardiff Oncology, Inc. (CRDF). They have executed 8 insider transactions totaling $130.0K over their tenure at the company.
Rodney S. Markin holds the position of Executive at Cardiff Oncology, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Rodney S. Markin has shown a buying trading pattern, with $130.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Rodney S. Markin was on Jun 20, 2018, when they purchased $35.0K worth of TROV shares. This transaction involved 41,200 shares at $0.85 per share.
Rodney S. Markin currently owns 263,430 shares of Cardiff Oncology, Inc. (CRDF), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Rodney S. Markin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Rodney S. Markin has 8 Form 4 filings on record as an insider at Cardiff Oncology, Inc..
Set alerts for Rodney S. Markin and 40,000+ other insiders.